Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > Guy latest video
View:
Post by Golddetector on Aug 06, 2022 8:32am

Guy latest video

Here the latest video I found for Guy talking mainly about cannabinol based drug with a panel. Since that Australian partnership we didn't hear anything. We need an update about reborn trials and Australian sites that were planned. 

Comment by Albr035 on Aug 06, 2022 8:54am
He found a video of the biggest scammer Guy Chamberland who is missing since the last RS, sure he will reappear once he needs to fill his banking account.
Comment by Savage97 on Aug 06, 2022 5:49pm
Great find!  Guy sounds very confident with TBP and the DIN # prescription medical cannabis market!! $$$
Comment by Normandt on Aug 06, 2022 6:30pm
For sure he is confident. This drug is approved in the USA already and a few other countries. It was even approved here in Canada 10 years ago. Then everybody knows that HC will approve it.....but the question is..."when?".
Comment by Albr035 on Aug 06, 2022 7:02pm
So confident and sure about the approval ? So explain the 90% drop ??! Your bluff doesn't match the reality!
Comment by Golddetector on Aug 08, 2022 7:29am
Below is what was published on July 14 ma&d. Last q had similar comment. Sounds close I thought it won't take more than weeks last q but here we are still waiting: "On June 6, 2022, the Company confirmed that it had completed the Annual Licence Review process for its Health Canada Drug Establishment Licence (“DEL”) and meets the regulatory requirements of C.01A.009 of the Food and ...more  
Comment by Albr035 on Aug 08, 2022 8:47am
Are you really dumb enough to post some old news and keep yourself optimistic about it ? Wake up you CEO is missing!
Comment by JohnnyRingo20 on Aug 08, 2022 8:55am
So they're still discussing stuff about the submission? That doesn't sound promising.  If the trials are complete and application submitted. They're should be no discussion about it a year later IF everything was submitted properly.  like really... seriously... over a year and still talking with health Canada about it. hopefully they dotted there I's and ...more  
Comment by Savage97 on Aug 08, 2022 11:15am
Wheels are turning and inhalation medicine that avoids toxicity build up will be a game changer with TBP leading the way!!!!!!!!!!!!!!!!!!!!!!$$$!!!!!!!!!!!!!!!!!!!!!!!!!
Comment by Albr035 on Aug 08, 2022 3:04pm
I don't think there is more investors to fool, you are already uncovered, waiting Dr Guy Chamberland to be handcuffed soon.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities